Global Artificial Pancreas Market 2022-2026

Global Artificial Pancreas Market 2022-2026

Technavio has been monitoring the artificial pancreas market and it is poised to grow by $ 450.95 mn during 2022-2026, progressing at a CAGR of 19.15% during the forecast period. Our report on the artificial pancreas market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and favorable regulations and guidelines. In addition, the rising global burden of diabetes is anticipated to boost the growth of the market as well.

The artificial pancreas market analysis includes the type segment and geographic landscape.

Technavio's artificial pancreas market is segmented as below:

By Type

• Threshold suspend device
• Non-threshold suspend device
• Control to range system
• Control to target system

By Geographical Landscape

• North America
• Europe
• Asia
• ROW

This study identifies the rising geriatric populationas one of the prime reasons driving the artificial pancreas market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on artificial pancreas market covers the following areas:

• Artificial pancreas market sizing
• Artificial pancreas market forecast
• Artificial pancreas market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial pancreas market vendors that include Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc. Also, the artificial pancreas market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, Tandem Diabetes Care Inc.